NanoViricides testing oral gummy and syrup Covid-19 treatment – Proactive Research Analyst
NanoViricides testing oral gummy and syrup Covid-19 treatment – Proactive Research Analyst
–News Direct–
Proactive research analyst John Savin speaks to Thomas Warner after releasing a new report on NanoViricides Inc (NYSE-A:NNVC), a development-stage company that is creating special-purpose nanomaterials for antiviral therapy. Savin gives an overview of what the company does, as well as its current operations and its financial situation. He highlights that NanoViricides is currently undertaking its first ever clinical trial, of an edible treatment for Covid-19 in India.
Contact Details
Proactive Investors
+1 604-688-8158
na-editorial@proactiveinvestors.com
View source version on newsdirect.com: https://newsdirect.com/news/nanoviricides-testing-oral-gummy-and-syrup-covid-19-treatment-proactive-research-analyst-811701760
NanoViricides
COMTEX_436780769/2655/2023-07-13T08:31:33
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No DigiShor journalist was involved in the writing and production of this article.
© 2017 VictorThemes - Elite Themeforest Author.